We

Agency’s arecommitment committed to deliveringpatient, apublic step-changeinvolvement inand theengagement

The wayMHRA’s wecommitment engageto withpatient, patientspublic involvement and theengagement public,is puttingincluded theirin views and interests at the heartagency’s Corporate ofPlan our decision-making and culture.2023-26.

We are takinga stepssignatory toof adoptthe shared acommitment moreto transparent,public responsiveinvolvement andin systematicresearch. approachRead tomore listeningin toour andblog Reflections involvingon patientsthe andshared thecommitment public.to public involvement.

Our approach to patientpatient, and public involvement and engagement

Our first Patient Involvement Strategy published published in October 2021 set out how we willwould engage and involve the public and patients at every step of the regulatory journey. Our approach was informed at the very outset through consultation with patients on what was important to them. The Independent Medicines and Medical Devices Safety Review also provided us with clear direction on where we could improve our engagement with patients, and the resulting strategy was then approved by our Patient Safety and Engagement Committee and Agency Board.

If you would like to read about some of our activities within the first year of the strategy, please see our One Year On report for more information.

What the Public and Patient Involvement and PublicEngagement CommunityTeam do

The PatientPatient, Public Involvement and PublicEngagement CommunityTeam (previously(PPIE) knownacts as thea Patientcentre Groupof Consultativeexpertise Forum)within wasthe establishedMHRA, inadvising Octoberand 2024supporting followingMHRA theteams reviewto ofplan, ourdesign strategy and howdeliver wehigh‑quality couldpatient improveand public involvement of our Patient and Publicengagement community.activities.

ItSome isof openthe toprojects peoplewhere withthe anpublic interestand inpatient medicinesengagement andhas medicalassisted devices,us andinclude:

Rare toDiseases

The patientMHRA groupshas whoset canup representa theRare viewsDisease ofConsortium theirto memberswork andwith feeda theserange intoof discussions.stakeholders Itincluding actspatient asrepresentatives athat meanssupport the development of bringinga thepatient- ‘patient/publicfocused voice’regulatory intoframework. theThe agency,framework towill assistaddress inthe ourunique developmentchallenges of policyrare ordiseases ourand approachsupport tothe atimely specificaccess regulatoryto orinnovative scientific research areas.therapies.

WeIn expect2025 participantsworkshops inand themeetings Communitytook toplace bewith ablepatients toand meetpatient therepresentatives followingto criteria:

• again demonstrabletheir interestviews inon medicinesa andrange medicalof devicesfundamental andissues for the roledevelopment theyof playthe inframework. improvingContinued healthpatient andinvolvement increasingfor qualitythis ofwork life
• anwill interestbe incrucial as the regulationpatient ofand medicinesrare anddisease medicalcommunity devices
• anhave interestthe inlived scienceexperience and research
• aexpertise commitment to enable the principlescreation of patienta andframework publicthat engagementbest meets their needs.

  ILAP

  The Innovative Licensing and involvement

• anAccess abilityPathway to(ILAP) drawis focused on theirgetting experiencesthe asmost atransformative patientnew andmedicines asto apatients consumerin ofthe medicinesUK andhealth medicalsystem devicesmore andquickly.

  In translate2025, thisthe intoPPSE team recruited a populationpool levelof perspective

• an20 interestLay inMembers championing(members patientof safety
• the commitmentpublic) to participatework inwith the workILAP ofteam over the agencynext by2 attendingyears. theThey Patientbring andthe Publicpublic, Communitypatient meetingsperspective and participatingvoice into electronicthe methodsassessment and selection of engagement
• anILAP abilityapplications.

  To toensure respectthat boundariesLay andMembers confidentiality

• anwere abilityable to contribute constructivelyeffectively, tothey discussions
• anreceived abilitya tocomprehensive communicateinduction effectively
• athat commitmentexplained to the agencyILAP values:
  • innovative
  • proactive
  • impartial
  • evidence-based
  • open
  • trustworthy

Theprocess, Communitytheir isrole managedwithin byin ourit Patient, Public and Stakeholderhow Engagementto teamassess andapplications comprisesfrom ofa representationnon-scientific fromperspective. patientLay groups/networksMembers andare charities/researcha charitieskey orpart individualof patientsthe orILAP carers.process.

What

Lay communityMember membersfeedback willhas do

Asprovided athe memberILAP ofteam thewith community,crucial youinsight can:

• Influencein andhow informto ourimprove workthe byassessment sharingof yourapplications insightsfor andfuture perspectives
• Helprounds. usThis toprocess improveof howcontinual weimprovement involvewill patients,continue carersgoing andforward.

  National Commission into the publicRegulation of AI in ourHealthcare

  The work

• StayNational informedCommission into the Regulation of ourAI keyin developments
• UseHealthcare youris livedan experience,expert, ornon‑statutory thatadvisory ofbody theestablished communityby youthe represent,MHRA to helpreview othersexisting toregulations beand engagedprovide withrecommendations ourfor work

Wea willfuture hostregulatory eventsframework focusedfor onartificial aintelligence specificin areahealthcare.

The work of the agency’sCommission work.includes Thisa willcomprehensive provideresearch communityand membersengagement toprogramme. learnKey moreengagement aboutactivities ourhave activitiesincluded:

• A andcall meetfor agencyevidence staff.survey
• Three Communitydeliberative memberssessions willheld alsoacross havethe opportunityUK, towith provideparticipants commentsselected (fromto reflect the patient/carerdemographics perspective)of oneach drafthost materialsregion.
• Three andfocus participategroups inwith surveystargeted thatseldom‑heard informcommunities: - theYoung developmentpeople - ofUnpaid ourcarers - work.
  People with learning difficulties

Get

Public involved

and Patient Community

WeThe continuePatient toand growPublic andCommunity evolve(PPC), andpreviously areknown keenas tothe gainPatient aGroup wideConsultative andForum, diversewas rangeestablished ofin patientsOctober and2024 conditionsfollowing fora thereview Patientof andour Publicstrategy Community.to Therestrengthen arehow twopatients typesand ofthe membershippublic –are individualinvolved orin voluntaryMHRA’s andwork.

The communityPPC sector.is Ifa youkey orMHRA yourtool organisationfor wouldpatient likeand topublic getinvolvement. involved,It eitherenables asthe aagency representativeto ofengage ameaningfully with patients and patient group,organisations orto charity/researchinform charity,regulatory orwork asand apolicy patientdevelopment, orhelping ato carer,shape signour updecision‑making.

Who usingcan join the relevantPPC?

The ‘ExpressionPPC ofis interest’open form.to Beforeindividuals youwith signan up,interest pleasein ensuremedicines thatand youmedical havedevices, readas andwell understoodas ourpatient Workinggroups Togetherand Agreement.

Expressionorganisations ofthat interestcan formrepresent –the Individual

Expressionviews of interesttheir formmembers. -The Organisation

PublicCommunity sessionshelps ofbring the Board

Eachpatient yearand wepublic aimvoice tointo holdMHRA sixpolicy sessionsdevelopment ofand theregulatory Agencyand Boardscientific meetingswork.

Members inare public.expected to:

See further

• Take detailspart ofin thesePPC publicmeetings sessions,and includingonline howengagement
• Use tolived registerexperience to attend.inform Youwider canperspectives
• Respect signconfidentiality
• Champion uppatient tosafety theand mailingmeaningful listinvolvement

As ifa PPC member, you wouldwill likehelp to beshape keptMHRA’s updatedwork aboutby Agencysharing Boardyour meetingsinsights, insupporting publicbetter andinvolvement  alsoof findpatients outand aboutthe whatpublic. isYou goingwill onbring inyour thelived MHRAexperience thatto mightsupport beMHRA ofengagement. interestYou towill you,have plusthe newsopportunity aboutto involvementgive activities feedback thaton aredraft happeningmaterials outsideand thetake MHRApart butin aresurveys linkedthat toinform our work.

Details

How aboutto theget agency’sinvolved

We governanceare cankeen beto foundbuild ona thediverse relevantand pagesinclusive forCommunity, ‘Ourrepresenting governance’a and ’Advisorywide bodies’ range includingof theirconditions, respectiveexperiences responsibilities and members.perspectives.

Agency’s

There commitmentare totwo patienttypes engagementof and involvement

membership:

Our

1. Individual commitmentmembers to(patients patientor carers)
2. Voluntary and publiccommunity engagementsector isorganisations

If includedyou inwould thelike agency’s Corporateto Planjoin, 2023-26.

Weplease arecomplete athe signatoryrelevant Expression of the sharedInterest commitmentform toand publicread involvementour inWorking research.Together ReadAgreement morebefore inapplying.

Working ourTogether blog ReflectionsAgreement

Expression onof theinterest sharedform commitment– toIndividual

Expression publicof involvementinterest form - Organisation.